<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Assessing Treatment Response of Osteolytic Lesions by Manual Volumetry, Automatic Segmentation, and RECIST in Experimental Bone Metastases" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/assessing-treatment-response-of-osteolytic-lesions-by-manual-volumetry-automatic-segmentation-and/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/assessing-treatment-response-of-osteolytic-lesions-by-manual-volumetry-automatic-segmentation-and/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2014-08-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Assessing Treatment Response of Osteolytic Lesions by Manual Volumetry, Automatic Segmentation, and RECIST in Experimental Bone Metastases" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T02:43:55+00:00","datePublished":"2014-08-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"Assessing Treatment Response of Osteolytic Lesions by Manual Volumetry, Automatic Segmentation, and RECIST in Experimental Bone Metastases","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/assessing-treatment-response-of-osteolytic-lesions-by-manual-volumetry-automatic-segmentation-and/"},"url":"https://clinicaltree.github.io/posts/assessing-treatment-response-of-osteolytic-lesions-by-manual-volumetry-automatic-segmentation-and/"}</script><title>Assessing Treatment Response of Osteolytic Lesions by Manual Volumetry, Automatic Segmentation, and RECIST in Experimental Bone Metastases | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Assessing Treatment Response of Osteolytic Lesions by Manual Volumetry, Automatic Segmentation, and RECIST in Experimental Bone Metastases</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Assessing Treatment Response of Osteolytic Lesions by Manual Volumetry, Automatic Segmentation, and RECIST in Experimental Bone Metastases</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1409504400" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Aug 31, 2014 </em> </span> <span> Updated <em class="" data-ts="1681094635" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Maren Bretschi PhD</a> </em>, <em> <a href="">Andrea Fränzle PhD</a> </em>, <em> <a href="">Maximilian Merz MD</a> </em>, <em> <a href="">Jens Hillengass MD</a> </em>, <em> <a href="">Wolfhard Semmler MD PhD</a> </em>, <em> <a href="">Rolf Bendl PhD</a> </em>, <em> <a href="">Tobias Bäuerle MD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="1681 words"> <em>9 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Aim of the study was to compare between volumetric and unidimensional approaches for treatment response monitoring in a nude rat model of experimental bone metastases. For the volumetric approach, an automated segmentation algorithm of osteolytic lesions was introduced and compared to manual volumetry.</p><h2 id="material-and-methods"><span class="mr-2">Material and Methods</span><a href="#material-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Nude rats bearing osteolytic metastases were treated with zoledronate and sunitinib and compared to controls. Treatment response was assessed longitudinally in vivo using flat-panel volumetric computed tomography at days 30, 35, 45, and 55 after tumor cell inoculation. The mean sizes and volumes of osteolytic lesions were determined according to response evaluation criteria in solid tumors (RECIST) and by automated and manual volumetry (software: MITK [The Medical Imaging Interaction Toolkit, Heidelberg, Germany] and VIRTUOS, Heidelberg, Germany).</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>In contrary to RECIST, the manual volumetric approach indicated a significant decrease in osteolytic lesion volume in response to treatment. The presented automatic segmentation algorithm for treatment monitoring identified bone metastases adequately and assessed changes in the osteolytic lesion volume over time according to manual volumetry.</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>In an animal model, volumetric treatment response assessment of osteolytic bone metastases is superior to unidimensional measurements, and automated volumetric segmentation may be a valuable alternative to manual volume determination.</p><p>Bone is the most common site of metastasis for breast and prostate cancer. Bone pain, pathologic fractures, and immobility are clinical complications of bone metastasis which can profoundly impair quality of life for long-term survivors . Treatment options for inhibiting breast cancer bone metastases are currently including the systemic treatment options bisphosphonates, chemotherapy, and hormone therapy. Furthermore, novel therapeutic approaches for metastatic breast cancer enclose antiangiogenic treatments .</p><p>Treatment response assessment of bone metastases is complicated because of the complex morphology of skeletal lesions and the slow turnover of bone matrix on therapy . Beside magnetic resonance imaging (MRI) for evaluation of bone marrow involvement of metastasis, computed tomography (CT) is commonly used in clinical practice to determine morphologic osseous changes after application of treatment. The commonly used classification system for therapy monitoring in solid tumors is the response evaluation criteria in solid tumors (RECIST) that is based on unidimensional measurement of primary tumors and metastases as determined by the largest lesion diameter . Bone metastases, however, have been considered as “immeasurable” in the initial version of these guidelines because of the complex morphology . In the revised RECIST guidelines (version 1.1), some additions have been made defining osteolytic or mixed lesions with identifiable soft tissue masses as measurable lesions by CT and MRI . Thus, measuring unidimensional diameters of the soft tissue component of skeletal metastases is the current standard for response evaluation.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="material-and-methods-1"><span class="mr-2">Material and methods</span><a href="#material-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="animal-model-and-treatment"><span class="mr-2">Animal Model and Treatment</span><a href="#animal-model-and-treatment" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="imaging-technique"><span class="mr-2">Imaging Technique</span><a href="#imaging-technique" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="imaging-data-analysis"><span class="mr-2">Imaging Data Analysis</span><a href="#imaging-data-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="response-evaluation-criteria-in-solid-tumors"><span class="mr-2">Response evaluation criteria in solid tumors</span><a href="#response-evaluation-criteria-in-solid-tumors" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="manual-volumetry"><span class="mr-2">Manual volumetry</span><a href="#manual-volumetry" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="automated-software-tool-for-the-analysis-of-osteolytic-lesions"><span class="mr-2">Automated software tool for the analysis of osteolytic lesions</span><a href="#automated-software-tool-for-the-analysis-of-osteolytic-lesions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-analysis"><span class="mr-2">Statistical analysis</span><a href="#statistical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="histologic-staining"><span class="mr-2">Histologic Staining</span><a href="#histologic-staining" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="therapy-response"><span class="mr-2">Therapy Response</span><a href="#therapy-response" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="recist-manual-measurement-unidimensional"><span class="mr-2">RECIST (Manual Measurement Unidimensional)</span><a href="#recist-manual-measurement-unidimensional" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AssessingTreatmentResponseofOsteolyticLesionsbyManualVolumetryAutomaticSegmentationandRECISTinExperimentalBoneMetastases/0_1s20S1076633214001585.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AssessingTreatmentResponseofOsteolyticLesionsbyManualVolumetryAutomaticSegmentationandRECISTinExperimentalBoneMetastases/0_1s20S1076633214001585.jpg" alt="Figure 1, Study results of parameters acquired with volumetric computed tomography from experimental bone metastases at days 30, 35, 45, and 55 after tumor cell inoculation. (a) Unidimensional measurement of osteolytic lesion sizes according to RECIST criteria (centimeter); (b) volumes of osteolyses as determined by manual segmentation (milliliter); and (c) volumes of osteolytic lesions as determined by automated segmentation (milliliter). Numbers for manual volumetry were reported previously (4) . Bars, standard error; * P &lt; .05; ** P &lt; .01)." class="lazyload" data-proofer-ignore></a></p><p>Table 1</p><p>Study Results</p><p>Day 30 Day 35 Day 45 Day 55 RECIST (cm) Control 0.29 ± 0.05 0.39 ± 0.07 0.50 ± 0.06 0.60 ± 0.09 Zoledronate 0.40 ± 0.06 0.42 ± 0.05 0.37 ± 0.07 0.41 ± 0.06 Sunitinib 0.37 ± 0.07 0.42 ± 0.04 0.44 ± 0.05 0.41 ± 0.05 Manual (mL) Control 0.04 ± 0.01 0.05 ± 0.01 0.08 ± 0.02 0.12 ± 0.04 Zoledronate 0.04 ± 0.01 0.05 ± 0.02 0.06 ± 0.02 0.06 ± 0.02 Sunitinib 0.04 ± 0.01 0.04 ± 0.01 0.04 ± 0.01 0.03 ± 0.01** Automatic (mL) Control 0.09 ± 0.04 0.18 ± 0.05 0.27 ± 0.09 0.32 ± 0.1 Zoledronate 0.07 ± 0.03 0.24 ± 0.14 0.15 ± 0.07 0.17 ± 0.08 Sunitinib 0.05 ± 0.02 0.14 ± 0.04 0.23 ± 0.05 0.17 ± 0.05</p><p>For in vivo experiments, all mean values from day 30, 35, 45, and 55 are given in absolute numbers ± standard error. Numbers for manual volumetry were reported previously .</p><p>Asterisks denote a significant difference between groups (** <em>P</em> &lt; .01).</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="manual-volumetry-1"><span class="mr-2">Manual volumetry</span><a href="#manual-volumetry-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="automated-volumetry"><span class="mr-2">Automated volumetry</span><a href="#automated-volumetry" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="histology"><span class="mr-2">Histology</span><a href="#histology" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AssessingTreatmentResponseofOsteolyticLesionsbyManualVolumetryAutomaticSegmentationandRECISTinExperimentalBoneMetastases/1_1s20S1076633214001585.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AssessingTreatmentResponseofOsteolyticLesionsbyManualVolumetryAutomaticSegmentationandRECISTinExperimentalBoneMetastases/1_1s20S1076633214001585.jpg" alt="Figure 2, Comparison between manual and automated segmentation with the Bland–Altman plot. Bland–Altman plots including data from small (a) , medium (b) , and large (c) bone metastases. Differences between osteolysis volumes derived from automated and manual segmentation approaches are plotted against the averages of the two techniques. The limits of agreement for the Bland–Altman analysis was specified as bias ± 2d (average difference ± 2 standard deviation of the difference)." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AssessingTreatmentResponseofOsteolyticLesionsbyManualVolumetryAutomaticSegmentationandRECISTinExperimentalBoneMetastases/2_1s20S1076633214001585.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AssessingTreatmentResponseofOsteolyticLesionsbyManualVolumetryAutomaticSegmentationandRECISTinExperimentalBoneMetastases/2_1s20S1076633214001585.jpg" alt="Figure 3, Representative segmentation results from automated volumetry and histology. Morphological aspects of experimental bone metastases as imaged by volumetric computed tomography in transversal, sagittal, and coronal orientation and trichrome staining for small (a) , medium (b) , and large (c) bone metastases. ‘‘T’’ indicates tumor, ‘‘B’’ bone tissue, “M” muscle, and “BM” bone marrow of skeletal metastases." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="comparison-between-manual-and-automated-segmentation"><span class="mr-2">Comparison Between Manual and Automated Segmentation</span><a href="#comparison-between-manual-and-automated-segmentation" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 2</p><p>Comparison Between Manual and Automated Segmentation (Bland–Altman Analysis)</p><p>Volume Mean Manual Mean Automatic Mean Difference Deviation Factor Small 0.02 0.05 0.03 2.2 Medium 0.05 0.18 0.12 3.4 Large 0.12 0.31 0.21 2.7 Mean Value 0.06 0.17 0.36 2.8</p><p>The mean values for manual and automatic segmentation, as well as the mean difference and deviation factor for the techniques, are given for small (0.008–0.029 mL), medium (0.03–0.078 mL), and large (0.079–0.309 mL) bone Metastases.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="acknowledgments"><span class="mr-2">Acknowledgments</span><a href="#acknowledgments" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Coleman R.E.: Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 2001; 27: pp. 165-176.</p><li><p>2. Bäuerle T., Merz M., Komljenovic D., et. al.: Drug-induced vessel remodeling in bone metastases as assessed by dynamic contrast enhanced magnetic resonance imaging and vessel size imaging: a longitudinal in vivo study. Clin Cancer Res 2010; 16: pp. 3215-3225.</p><li><p>3. Burstein H.J., Elias A.D., Rugo H.S., et. al.: Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. J Clin Oncol 2008; 26: pp. 1810-1816.</p><li><p>4. Bäuerle T., Semmler W.: Imaging response to systemic therapy for bone metastases. Eur Radiol 2009; 19: pp. 2495-2507.</p><li><p>5. Miller A.B., Hoogstraten B., Staquet M., et. al.: Reporting results of cancer treatment. Cancer 1981; 47: pp. 207-214.</p><li><p>6. Therasse P., Arbuck S.G., Eisenhauer E.A., et. al.: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: pp. 205-216.</p><li><p>7. Eisenhauer E.A., Therasse P., Bogaerts J., et. al.: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: pp. 228-247.</p><li><p>8. Heussel C.P., Meier S., Wittelsberger S., et. al.: Follow-up CT measurement of liver malignoma according to RECIST and WHO vs. volumetry. Rofo 2007; 179: pp. 958-964.</p><li><p>9. Yankelevitz D.F., Reeves A.P., Kostis W.J., et. al.: Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. Radiology 2000; 217: pp. 251-256.</p><li><p>10. Fabel M., von Tengg-Kobligk H., Giesel F.L., et. al.: Semi-automated volumetric analysis of lymph node metastases in patients with malignant melanoma stage III/IV–a feasibility study. Eur Radiol 2008; 18: pp. 1114-1122.</p><li><p>11. Gao L., Heath D.G., Kuszyk B.S., et. al.: Automatic liver segmentation technique for three-dimensional visualization of CT data. Radiology 1996; 201: pp. 359-364.</p><li><p>12. Bäuerle T., Adwan H., Kiessling F., et. al.: Characterization of a rat model with site-specific bone metastasis induced by MDA-MB-231 breast cancer cells and its application to the effects of an antibody against bone sialoprotein. Int J Cancer 2005; 115: pp. 177-186.</p><li><p>13. Fränzle A., Bretschi M., Bäuerle T., et. al.: A quantification strategy for missing bone mass in case of osteolytic bone lesions. Med Phys 2013; 40: pp. 123501.</p><li><p>14. Bendl R.: Virtual therapy simulation. New technologies in radiation oncology.2006.Springer VerlagBerlin Heidelberg New Yorkpp. 179-186.</p><li><p>15. Erasmus J.J., Gladish G.W., Broemeling L., et. al.: Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response. J Clin Oncol 2003; 21: pp. 2574-2582.</p><li><p>16. Thiesse P., Ollivier L., Di Stefano-Louineau D., et. al.: Response rate accuracy in oncology trials: reasons for interobserver variability. Groupe Francais d’Immunotherapie of the Federation Nationale des Centres de Lutte Contre le Cancer. J Clin Oncol 1997; 15: pp. 3507-3514.</p><li><p>17. Zhao B., Schwartz L.H., Moskowitz C.S., et. al.: Lung cancer: computerized quantification of tumor response initial results. Radiology 2006; 241: pp. 892-898.</p><li><p>18. Marten K., Auer F., Schmidt S., et. al.: Automated CT volumetry of pulmonary metastases: the effect of a reduced growth threshold and target lesion number on the reliability of therapy response assessment using RECIST criteria. Eur Radiol 2007; 17: pp. 2561-2571.</p><li><p>19. Vogel M.N., Vonthein R., Schmucker S., et. al.: Automated pulmonary nodule volumetry with an optimized algorithm. Accuracy at different slice thicknesses compared to unidimensional and bidimensional measurements. Rofo 2008; 180: pp. 791-797.</p><li><p>20. Ratain M.J., Eckhardt S.G.: Phase II studies of modern drugs directed against new targets: if you are fazed, too, then resist RECIST. J Clin Oncol 2004; 22: pp. 4442-4445.</p><li><p>21. Bretschi M., Merz M., Komljenovic D., et. al.: Cilengitide inhibits metastatic bone colonization in a nude rat model. Oncol Rep 2011; 26: pp. 843-851.</p><li><p>22. Merz M., Komljenovic D., Semmler , et. al.: Quantitative contrast-enhanced ultrasound for imaging antiangiogenic treatment response in experimental osteolytic breast cancer bone metastases. Invest Radiol 2012; 47: pp. 422-429.</p><li><p>23. Bäuerle T., Bartling S., Berger M., et. al.: Imaging anti-angiogenic treatment response with DCE-VCT, DCE-MRI and DWI in an animal model of breast cancer bone metastasis. Eur J Radiol 2010; 73: pp. 280-287.</p><li><p>24. Nakayama Y., Li Q., Katsuragawa S., et. al.: Automated hepatic volumetry for living related liver transplantation at multisection CT. Radiology 2006; 240: pp. 743-748.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-21/'>Volume 21</a>, <a href='/categories/issue-9/'>Issue 9</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Assessing%20Treatment%20Response%20of%20Osteolytic%20Lesions%20by%20Manual%20Volumetry,%20Automatic%20Segmentation,%20and%20RECIST%20in%20Experimental%20Bone%20Metastases%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fassessing-treatment-response-of-osteolytic-lesions-by-manual-volumetry-automatic-segmentation-and%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Assessing%20Treatment%20Response%20of%20Osteolytic%20Lesions%20by%20Manual%20Volumetry,%20Automatic%20Segmentation,%20and%20RECIST%20in%20Experimental%20Bone%20Metastases%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fassessing-treatment-response-of-osteolytic-lesions-by-manual-volumetry-automatic-segmentation-and%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fassessing-treatment-response-of-osteolytic-lesions-by-manual-volumetry-automatic-segmentation-and%2F&text=Assessing%20Treatment%20Response%20of%20Osteolytic%20Lesions%20by%20Manual%20Volumetry,%20Automatic%20Segmentation,%20and%20RECIST%20in%20Experimental%20Bone%20Metastases%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/a-reader-study-comparing-prospective-tomosynthesis-interpretations-with-retrospective-readings-of-th/"><div class="card-body"> <em class="small" data-ts="1409504400" data-df="ll" > Aug 31, 2014 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A Reader Study Comparing Prospective Tomosynthesis Interpretations with Retrospective Readings of the Corresponding FFDM Examinations</h3><div class="text-muted small"><p> Rationale and Objectives To compare performance of prospective interpretations of clinical tomosynthesis (digital breast tomosynthesis [DBT]) plus full-field digital mammography (FFDM) examination...</p></div></div></a></div><div class="card"> <a href="/posts/applying-quantitative-benefit-risk-analysis-to-aid-regulatory-decision-making-in-diagnostic-imaging/"><div class="card-body"> <em class="small" data-ts="1409504400" data-df="ll" > Aug 31, 2014 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Applying Quantitative Benefit–Risk Analysis to Aid Regulatory Decision Making in Diagnostic Imaging</h3><div class="text-muted small"><p> Rationale and Objectives Health agencies making regulatory marketing-authorization decisions use qualitative and quantitative approaches to assess expected benefits and expected risks associated w...</p></div></div></a></div><div class="card"> <a href="/posts/appropriateness-and-imaging-utilization/"><div class="card-body"> <em class="small" data-ts="1409504400" data-df="ll" > Aug 31, 2014 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Appropriateness and Imaging Utilization</h3><div class="text-muted small"><p> Modern imaging methods have been transformative in improving medical care. Cross-sectional imaging has largely eliminated the need for invasive “exploratory” surgery and is widely used to triage ac...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/assessing-the-impact-of-prevalence-expectations-on-radiologists-behavior/" class="btn btn-outline-primary" prompt="Older"><p>Assessing the Impact of Prevalence Expectations on Radiologists' Behavior</p></a> <a href="/posts/breast-dce-mri/" class="btn btn-outline-primary" prompt="Newer"><p>Breast DCE-MRI</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
